A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

Part of paid clinical trials in Tempe, Arizona.

Sponsor
Eli Lilly and Company
Study ID
NCT05706506
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The main purpose of this study is to investigate the effects of switching from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy to tirzepatide glucose-dependent insulinotropic polypeptide (GIP) GLP-1 RA agonist in participants with type 2 diabetes (T2D).

Key Dates

Start date
Mar 8, 2023
Status verified
Dec 2024
Primary completion
Oct 31, 2023
Completion
Oct 31, 2023

Study Design

Enrollment
152 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 5 milligrams (mg) Tirzepatide
    Participants received 5 mg tirzepatide subcutaneously administered once weekly for 12 weeks.

Primary Outcome Measure

Change From Baseline in Hemoglobin A1c (HbA1c) [ Time Frame: Baseline, Week 12 ]

Locations (32)

FacilityCityStateZIPSite coordinators
Fiel Family and Sports Medicine PCTempeArizona85283-
New Hope Research DevelopmentCoronaCalifornia92882-
Velocity Clinical Research, GardenaGardenaCalifornia90247-
Velocity Clinical Research, Huntington ParkHuntington ParkCalifornia90255-
Velocity Clinical Research, Huntington ParkLos AngelesCalifornia90057-
Valley Clinical Trials, Inc.NorthridgeCalifornia91325-
Dream Team Clinical ResearchPomonaCalifornia91767-
Scripps Whittier Diabetes InstituteSan DiegoCalifornia92121-1520-
Metabolic Institute of AmericaTarzanaCalifornia91356-3551-
CMR of Greater New Haven, LLCWaterburyConnecticut06708-
Velocity Clinical Research, Hallandale BeachHallandaleFlorida33009-
East Coast Institute for Research, LLCJacksonvilleFlorida32204-
Florida Institute For Clinical Research, LLCOrlandoFlorida32825-
New Tampa HealthTampaFlorida33603-3402-
Georgia Clinical ResearchLawrencevilleGeorgia30044-5896-
Endocrine Research Solutions, Inc.RoswellGeorgia30076-
Velocity Clinical Research, ValparaisoValparaisoIndiana46383-
Iowa Diabetes and Endocrinology Research CenterWest Des MoinesIowa50265-
Cotton O'Neil ClinicTopekaKansas66606-
Versailles Family MedicineVersaillesKentucky40383-1947-
Endocrine and Metabolic ConsultantsRockvilleMaryland20852-
Clinical Research ProfessionalsChesterfieldMissouri63005-
Clinical Research of South NevadaLas VegasNevada89121-
Palm Research Center TenayaLas VegasNevada89128-
Advanced Medical ResearchMaumeeOhio43537-9402-
Conrad Clinical ResearchEdmondOklahoma73013-
Mountain View Clinical Research, Inc.GreenvilleSouth Carolina29607-
Texas Diabetes & Endocrinology, P.A.AustinTexas78731-4309-
North Texas Endocrine CenterDallasTexas75231-
Memorial City Endocrine ConsultantsHoustonTexas77043-2742-
Consano Clinical Research, LLCShavano ParkTexas78231-
ClinPoint TrialsWaxahachieTexas75165-

Find similar trials in Tempe, AZ

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Fiel Family and Sports Medicine PC· Tempe, AZNew Hope Research Development· Corona, CAVelocity Clinical Research, Gardena· Gardena, CAVelocity Clinical Research, Huntington Park· Huntington Park, CAVelocity Clinical Research, Huntington Park· Los Angeles, CAValley Clinical Trials, Inc.· Northridge, CA

Related Studies